300 Participants Needed

Online Advance Care Planning Tool for Cognitive Impairment

(Portal-Voice Trial)

JG
EL
Overseen ByErica Lawrence
Age: 65+
Sex: Any
Trial Phase: Academic
Sponsor: Wake Forest University Health Sciences
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment ACPVoice, ACP Portal-Based Tool, ACPVoice for cognitive impairment?

The development of the ACPVoice tool involved engaging users with cognitive impairment to improve their understanding and navigation of advance care planning, suggesting it could effectively help them engage in these discussions.12345

Is the ACPVoice tool safe for use in humans?

The ACPVoice tool, designed for advance care planning in people with cognitive impairment, underwent testing with participants to improve understanding and ease of use. No safety concerns were reported during the development and testing process.13678

How is the ACPVoice treatment different from other treatments for cognitive impairment?

ACPVoice is unique because it is an online tool specifically designed to help people with cognitive impairment engage in advance care planning (ACP) by using a patient portal. It focuses on improving understanding and communication about future medical decisions, which is different from traditional treatments that may not address these specific needs.237910

What is the purpose of this trial?

The purpose of this research is to examine the feasibility of using a patient portal based advance care planning (ACP) tool to improve ACP discussions and documentation in persons living with cognitive impairment in outpatient primary care.

Research Team

JG

Jennifer Gabbard, MD

Principal Investigator

Wake Forest University Health Sciences

Eligibility Criteria

This trial is for community-dwelling adults with cognitive impairment who are under outpatient primary care. The study aims to include those who may benefit from improved discussions and documentation of their future healthcare preferences.

Inclusion Criteria

I am 65 years old or older.
I've seen my primary care doctor in the last year and have another appointment scheduled within 6 months.
Diagnosis of recognized or probable mild cognitive impairment or mild dementia or elevated eRADAR score
See 1 more

Exclusion Criteria

Enrolled in hospice
Lives in a long-term care facility
Severe vision impairment/blindness (as they need to be able to read portal messages)
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention Implementation

Participants receive the ACPVoice tool via the patient portal, paired with a motivational message, to improve advance care planning discussions and documentation.

6 months

Follow-up

Participants are monitored for the effectiveness of the ACPVoice tool in improving advance care planning documentation and discussions.

6 months

Treatment Details

Interventions

  • ACPVoice
Trial Overview The study is testing ACPVoice, a tool designed for advance care planning (ACP), against the standard of care in ACP. It will evaluate how well ACPVoice facilitates conversations and decision-making about future healthcare needs.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: ACPVoice InterventionExperimental Treatment1 Intervention
Community-dwelling persons living with cognitive impairment aged 65 and older with known or probable mild cognitive impairment or dementia or elevated eRADAR score (with decision-making capacity), who are affiliated with the Atrium-Wake Forest Baptist Health , have a primary care physician at one of the participating sites, and have an active patient portal account.
Group II: Standard of CareActive Control1 Intervention
Community-dwelling persons living with cognitive impairment aged 65 and older with known or probable mild cognitive impairment or dementia or elevated eRADAR score (with decision-making capacity), who are affiliated with the Atrium-Wake Forest Baptist Health, have a primary care physician within the Atrium-Wake Forest Baptist Health Network, and have an active patient portal account.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Wake Forest University Health Sciences

Lead Sponsor

Trials
1,432
Recruited
2,506,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Findings from Research

The MCI ENACT intervention, designed for advance care planning in individuals with mild cognitive impairment, was positively received by participants, who found group discussions helpful and expressed a strong desire for such discussions.
Although the intervention was deemed acceptable, challenges in recruiting participants highlighted the need for improved strategies to implement this program effectively in clinical settings.
Human-Centered Design of an Advance Care Planning Group Visit for Mild Cognitive Impairment.Daddato, AE., Staton, EW., Bettcher, BM., et al.[2022]
The interactive web-based advance care planning (ACP) program significantly increased engagement in ACP among 147 participants with chronic diseases, with scores rising from 2.8 to 3.0 two months after completion (P<.001).
Participants found the program to be usable and understandable, with high satisfaction ratings, indicating it can effectively support initial discussions about treatment preferences and serve as a valuable tool for healthcare professionals.
The Web-Based Advance Care Planning Program "Explore Your Preferences for Treatment and Care": Development, Pilot Study, and Before-and-After Evaluation.van der Smissen, D., Rietjens, JAC., van Dulmen, S., et al.[2022]
The development of the ACPVoice tool involved cognitive interviews with 20 participants, including individuals with mild cognitive impairment and their care partners, to ensure the tool was understandable and user-friendly for older adults with cognitive challenges.
Revisions to the wording and format of the tool significantly enhanced comprehension and response accuracy, suggesting that such tailored approaches can effectively engage community-dwelling individuals with cognitive impairment in advance care planning discussions.
Development of an Advance Care Planning Portal-Based Tool for Community-Dwelling Persons Living With Cognitive Impairment: The ACPVoice Tool.Gabbard, J., Strahley, AE., Pajewski, NM., et al.[2023]

References

Human-Centered Design of an Advance Care Planning Group Visit for Mild Cognitive Impairment. [2022]
The Web-Based Advance Care Planning Program "Explore Your Preferences for Treatment and Care": Development, Pilot Study, and Before-and-After Evaluation. [2022]
Development of an Advance Care Planning Portal-Based Tool for Community-Dwelling Persons Living With Cognitive Impairment: The ACPVoice Tool. [2023]
Sharing Health Care Wishes in Primary Care (SHARE) among older adults with possible cognitive impairment in primary care: Study protocol for a randomized controlled trial. [2023]
Measuring Advance Care Planning: Optimizing the Advance Care Planning Engagement Survey. [2021]
Advance Directive and POLST Documentation in Decedents With Dementia at a Memory Care Center: The Importance of Early Advance Care Planning. [2023]
Engaging Diverse Older Adults With Cognitive Impairment and Caregivers in Advance Care Planning: A Pilot Study of the Interactive PREPARE Website. [2023]
Making the Informal Formal: Discussing and Completing Advance Care Plans in Care Dyads with Cognitive Impairment. [2022]
The advance care planning PREPARE study among older Veterans with serious and chronic illness: study protocol for a randomized controlled trial. [2018]
Publicly Available, Interactive Web-Based Tools to Support Advance Care Planning: Systematic Review. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity